QuidelOrtho [QDEL] vs Bio-Rad Laboratories [BIO] Detailed Stock Comparison

QuidelOrtho

NASDAQ
Loading...

Bio-Rad Laboratories

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: QuidelOrtho wins in 6 metrics, Bio-Rad Laboratories wins in 12 metrics, with 0 ties. Bio-Rad Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricQuidelOrthoBio-Rad LaboratoriesBetter
P/E Ratio (TTM)-0.9226.74QuidelOrtho
Price-to-Book Ratio0.671.13QuidelOrtho
Debt-to-Equity Ratio100.3319.73Bio-Rad Laboratories
PEG Ratio-0.01-0.23Bio-Rad Laboratories
EV/EBITDA7.8219.64QuidelOrtho
Profit Margin (TTM)-17.01%12.50%Bio-Rad Laboratories
Operating Margin (TTM)-0.73%12.19%Bio-Rad Laboratories
EBITDA Margin (TTM)N/A12.19%N/A
Return on Equity-15.64%4.59%Bio-Rad Laboratories
Return on Assets (TTM)1.36%1.59%Bio-Rad Laboratories
Free Cash Flow (TTM)$-112.10M$266.20MBio-Rad Laboratories
1-Year Return-32.13%-10.12%Bio-Rad Laboratories
Price-to-Sales Ratio (TTM)0.693.23QuidelOrtho
Enterprise Value$4.53B$8.06BBio-Rad Laboratories
EV/Revenue Ratio1.653.16QuidelOrtho
Gross Profit Margin (TTM)44.78%52.99%Bio-Rad Laboratories
Revenue per Share (TTM)$41$92Bio-Rad Laboratories
Earnings per Share (Diluted)$-6.84$11.09Bio-Rad Laboratories
Beta (Stock Volatility)0.270.97QuidelOrtho
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

QuidelOrtho vs Bio-Rad Laboratories Stock Performance Analysis

Loading Price Chart...

QuidelOrtho
Bio-Rad Laboratories
QuidelOrtho Stock Overview | Bio-Rad Laboratories Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
QuidelOrtho0.54%-10.85%-2.14%-9.60%6.34%-38.14%
Bio-Rad Laboratories2.13%1.64%4.29%20.78%37.33%-7.15%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
QuidelOrtho-32.13%-63.48%-89.09%52.16%124.86%166.35%
Bio-Rad Laboratories-10.12%-23.28%-45.59%118.43%232.16%444.17%

News Based Sentiment: QuidelOrtho vs Bio-Rad Laboratories

QuidelOrtho

News based Sentiment: MIXED

October presented a complex picture for QuidelOrtho, with positive industry tailwinds offset by analyst downgrades, increased debt costs, and concerns about revenue exposure to China. While the company is focused on improving efficiency and launching new products, the overall narrative is one of significant challenges and uncertainties, making it a mixed investment story.

View QuidelOrtho News Sentiment Analysis

Bio-Rad Laboratories

News based Sentiment: MIXED

October presented a mixed bag for Bio-Rad, with positive developments like new product launches and a key partnership countered by an analyst downgrade and a history of underperformance. The conflicting signals create uncertainty, making it a moderately significant month for investors.

View Bio-Rad Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: QuidelOrtho vs Bio-Rad Laboratories

MetricQDELBIO
Market Information
Market Cap i$1.89B$8.14B
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i1,487,820213,490
90 Day Avg. Volume i1,319,670216,453
Last Close$27.86$302.83
52 Week Range$22.05 - $49.45$211.43 - $387.99
% from 52W High-43.66%-21.95%
All-Time High$306.72 (Aug 03, 2020)$832.70 (Aug 30, 2021)
% from All-Time High-90.92%-63.63%
Growth Metrics
Quarterly Revenue Growth-0.04%0.02%
Quarterly Earnings Growth-0.04%0.02%
Financial Health
Profit Margin (TTM) i-0.17%0.13%
Operating Margin (TTM) i-0.01%0.12%
Return on Equity (TTM) i-0.16%0.05%
Debt to Equity (MRQ) i100.3319.73
Cash & Liquidity
Book Value per Share (MRQ)$41.25$263.42
Cash per Share (MRQ)$2.25$50.76
Operating Cash Flow (TTM) i$200.40M$534.20M
Levered Free Cash Flow (TTM) i$410.38M$223.40M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: QuidelOrtho vs Bio-Rad Laboratories

MetricQDELBIO
Price Ratios
P/E Ratio (TTM) i-0.9226.74
Forward P/E i10.4525.45
PEG Ratio i-0.01-0.23
Price to Sales (TTM) i0.693.23
Price to Book (MRQ) i0.671.13
Market Capitalization
Market Capitalization i$1.89B$8.14B
Enterprise Value i$4.53B$8.06B
Enterprise Value Metrics
Enterprise to Revenue i1.653.16
Enterprise to EBITDA i7.8219.64
Risk & Other Metrics
Beta i0.270.97
Book Value per Share (MRQ) i$41.25$263.42

Financial Statements Comparison: QuidelOrtho vs Bio-Rad Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)QDELBIO
Revenue/Sales i$613.90M$585.40M
Cost of Goods Sold i$339.00M$279.40M
Gross Profit i$274.90M$306.00M
Research & Development i$45.70M$73.50M
Operating Income (EBIT) i$-1.80M$23.70M
EBITDA i$100.00M$98.50M
Pre-Tax Income i$-229.60M$83.40M
Income Tax i$25.80M$19.40M
Net Income (Profit) i$-255.40M$64.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)QDELBIO
Cash & Equivalents i$127.10M$521.40M
Total Current Assets i$1.26B$3.04B
Total Current Liabilities i$1.05B$506.60M
Long-Term Debt i$2.27B$1.33B
Total Shareholders Equity i$3.00B$6.68B
Retained Earnings i$123.10M$7.48B
Property, Plant & Equipment i$2.35B$681.70M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)QDELBIO
Operating Cash Flow i$41.90M$156.00M
Capital Expenditures i$-56.20M$-34.40M
Free Cash Flow i$9.40M$95.50M
Debt Repayment i$-36.00M$-100,000
Common Stock Repurchase iN/A$-101.90M

Short Interest & Institutional Ownership Analysis

MetricQDELBIO
Shares Short i8.15M1.11M
Short Ratio i7.034.84
Short % of Float i0.20%0.06%
Average Daily Volume (10 Day) i1,487,820213,490
Average Daily Volume (90 Day) i1,319,670216,453
Shares Outstanding i67.26M28.01M
Float Shares i62.65M21.67M
% Held by Insiders i0.01%0.16%
% Held by Institutions i1.17%0.90%

Dividend Analysis & Yield Comparison: QuidelOrtho vs Bio-Rad Laboratories

MetricQDELBIO
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A